Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease

Published:2009-10 Issue:4 Volume:154 Page:194-201
ISSN:1931-5244
Container-title:Translational Research
language:en
Short-container-title:Translational Research

Author:

Miele Luca,Forgione Alessandra,La Torre Giuseppe,Vero Vittoria,Cefalo Consuelo,Racco Simona,Vellone Valerio G.,Vecchio Fabio M.,Gasbarrini Giovanni,Rapaccini Gian Lodovico,Neuman Manuela G.,Grieco Antonio

Publisher

Elsevier BV

Subject

Biochemistry (medical),Public Health, Environmental and Occupational Health,General Medicine,Physiology (medical)

Reference45 articles.

1. Liver fibrosis in overweight patients;Ratziu;Gastroenterology,2000

2. Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study;de Marco;Diabetes Care,1999

3. Nonalcoholic fatty liver disease;Angulo;N Engl J Med,2002

4. Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status;Di Bisceglie;Am J Gastroenterol,2003

5. History, heterogeneity developmental biology and functions of quiescent hepatic stellate cells;Geerts;Semin Liver Dis,2001

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced liver fibrosis score is stable after withdrawal in patients with heavy alcohol consumption: A pilot study;Alcohol, Clinical and Experimental Research;2024-04-15

2. Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease;World Journal of Hepatology;2023-05-27

3. Applications of Quantitative Systems Pharmacology (QSP) in Drug Development for NAFLD and NASH and Its Regulatory Application;Pharmaceutical Research;2022-05-24

4. Intestinal Barrier and Permeability in Health, Obesity and NAFLD;Biomedicines;2021-12-31

5. Functional Foods for the Management of Non-Alcoholic Fatty Liver Disease;Functional Foods - Phytochemicals and Health Promoting Potential;2021-11-10